Great Debates in Solid Tumors focuses on the latest clinical advancements and evolving standards in women`s oncology through expert debates, case-based discussions, and networking.
Topics
- Biomarker testing in solid tumors
- State-of-the-art management of localized gynecologic cancers
- Use of antibody-drug conjugates in treatment strategies
- Frontline targeted therapies for advanced cancers
- Optimizing immune checkpoint inhibitors in cervical cancer
- Novel endocrine therapy approaches
- Strategies for recurrent disease after PARP inhibitor maintenance
- Emerging treatment options for hormone receptor-positive breast cancer
- Sequencing therapies for ovarian cancer
Who should Attend
- Oncologists and cancer researchers
- Gynecologic oncology specialists
- Medical professionals in women`s cancer treatment
- Pharmaceutical and biotechnology representatives
- Healthcare policymakers and regulators
- Clinical trial investigators
- Nurses and allied healthcare professionals
